Package 0615-8512-39

Brand: labetalol hydrochloride

Generic: labetalol hydrochloride
NDC Package

Package Facts

Identity

Package NDC 0615-8512-39
Digits Only 0615851239
Product NDC 0615-8512
Description

30 TABLET, FILM COATED in 1 BLISTER PACK (0615-8512-39)

Marketing

Marketing Status
Marketed Since 2024-06-14
Brand labetalol hydrochloride
Generic labetalol hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "7af3cd76-a5ca-406d-9455-d442f8d658d0", "openfda": {"unii": ["1GEV3BAW9J"], "rxcui": ["896758", "896762"], "spl_set_id": ["30280d40-28df-4c88-93bd-357a7c528906"], "manufacturer_name": ["NCS HealthCare of KY, LLC dba Vangard Labs"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BLISTER PACK (0615-8512-39)", "package_ndc": "0615-8512-39", "marketing_start_date": "20240614"}], "brand_name": "Labetalol Hydrochloride", "product_id": "0615-8512_7af3cd76-a5ca-406d-9455-d442f8d658d0", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Adrenergic beta-Antagonists [MoA]", "beta-Adrenergic Blocker [EPC]"], "product_ndc": "0615-8512", "generic_name": "Labetalol Hydrochloride", "labeler_name": "NCS HealthCare of KY, LLC dba Vangard Labs", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Labetalol Hydrochloride", "active_ingredients": [{"name": "LABETALOL HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA209603", "marketing_category": "ANDA", "marketing_start_date": "20210527", "listing_expiration_date": "20261231"}